| Literature DB >> 24911400 |
Yong Guo1, Vanda A Lennon2, Bogdan F Gh Popescu3, Carrie Katherine Grouse4, Jordan Topel4, Margherita Milone1, Hans Lassmann5, Joseph E Parisi2, Sean J Pittock2, Dusan Stefoski4, Roumen Balabanov4, Claudia F Lucchinetti1.
Abstract
IMPORTANCE: Documentation of muscle pathology compatible with targeting of sarcolemmal aquaporin-4 (AQP4) by complement-activating IgG implies involvement of organs beyond the central nervous system in neuromyelitis optica spectrum disorders. OBSERVATIONS: We report on a 51-year-old woman who had relapsing optic neuritis, transverse myelitis, AQP4-IgG seropositivity, and recurrent myalgias with hyperCKemia. A muscle biopsy revealed scattered myofibers with internal nuclei, atrophy, and regeneration but no necrosis. Mild inflammatory exudates, in endomysial and perivascular spaces, consisted of lymphocytes, histiocytes, and scattered eosinophils. The sarcolemma exhibited loss of AQP4 and deposition of IgG and complement activation products, characteristics not seen in control biopsy samples of healthy muscle and immune-mediated myopathies. CONCLUSIONS AND RELEVANCE: Recurrent hyperCKemia accompanying AQP4-IgG seropositivity reflects targeting of skeletal muscle AQP4 by pathogenic IgG. The entity of autoimmune AQP4 myopathy extends the neuromyelitis optica spectrum beyond the central nervous system.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24911400 DOI: 10.1001/jamaneurol.2014.775
Source DB: PubMed Journal: JAMA Neurol ISSN: 2168-6149 Impact factor: 18.302